ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Gross profit, 2025
- $3.0B
- YoY, 2025
- +56.4%
- 5-year CAGR
- +48.6%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $3.0B | +56.4% |
| 2024 | $1.9B | +24.5% |
| 2023 | $1.6B | +73.9% |
| 2022 | $897M | +23.0% |
| 2021 | $729M | +74.2% |
| 2020 | $419M | +115.0% |
| 2019 | $195M | +166.3% |
| 2018 | $73M | −18.7% |
| 2017 | $90M | — |